This report assesses the healthcare and economic burden of the
hepatitis C virus (HCV) infection in the UK. It used a cohort simulation
model to estimate the prevalence of HCV infection, including the number
of persons who live with HCV infection at different disease stages, and
the number of deaths that can be attributed to HCV infection through to
2035. It also examines the healthcare and societal costs that are
associated with HCV infection under different scenarios of diagnosis and
treatment rates.
